Start-Up Previews, April 2012
This Month's Profile Group, Vaccine Investment Gets A Shot In The Arm, features profiles of Genocea Biosciences, Imaxio, Selecta Biosciences and TremRx. Plus these Start-Ups Across Health Care: Bluegrass Vascular Technologies, Haldor Advanced Technologies and Targovax.
You may also be interested in...
Haldor Advanced Technologies Ltd.’s ORLocate surgical instrument tracking and asset management system uses RFID to automatically track, trace, monitor and manage the life cycle of instruments and consumables within the hospital – before, during and after a surgical procedure. In addition to managing the logistical chain and the specific location of an instrument at any point in time, ORLocate is designed to be a comprehensive workflow management system that provides statistical and processing data, par-level and inventory management and preventive maintenance.
Central venous catheters are commonly employed to deliver long-term dialysis, nutrition and chemotherapy, but nearly 10% of patients have an upper-extremity venous occlusion that renders the vein impenetrable by standard access techniques. When access is not possible through traditional “outside-in” routes, Bluegrass Vascular Technologies’ Surfacer system allows for central venous access through the femoral vein in the leg. The device features a bullet-shaped catheter tip with a proprietary side-exit needle that allows the physician to enter into the occlusion and create a new tissue channel, from the inside out.
In Vivo's editors pick January's most significant deals, including Roche's acquisition of Flatiron and Moderna's latest big private fundraising. (Free article.)